At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
etafilcon A +2 moredevice
Likely dose
Not stated in record
Key inclusion· 6
- ✓Age 18 years or older with full legal capacity
- ✓Existing soft contact lens wearers or previous contact lens wear experience
- ✓Able to wear study lenses for at least 8 hours daily
- ✓At least 6/9 visual acuity in each eye with study lenses
Key exclusion· 8
- ✕Any ocular disorder that would contraindicate contact lens wear
- ✕Systemic disorder or infectious disease contraindicating contact lens wear
- ✕Prior ocular surgery including corneal refractive surgery
- ✕Less than 6/9 visual acuity in either eye with study lenses
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Clinical Performance and Subjective Preference Out of Three Cosmetic Contact Lenses (Limbal Ring-enhancing Lenses, LRE Lenses)
In Brief
A clinical study evaluating etafilcon A, methafilcon A - Interozzo, and 1 other intervention for Myopia. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the clinical performance and subject's preference out of three LRE (Limbal Ring Enhancing) lens types: etafilcon A (Johnson\&Johnson), methafilcon A (Interozzo), and methafilcon A (CooperVision).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartMay 2017
Primary CompletionJun 2017
TodayJul 2026
First PostedMay 1, 2017
Enrollment StartMay 23, 2017
Primary CompletionJun 24, 2017
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.2 years ago
Interventions
etafilcon Adevice
contact lens
methafilcon A - Interozzodevice
contact lens
methafilcon A - CVI (CooperVision)device
contact lens